Jing Hu

4.1k total citations
167 papers, 2.8k citations indexed

About

Jing Hu is a scholar working on Molecular Biology, Pulmonary and Respiratory Medicine and Cancer Research. According to data from OpenAlex, Jing Hu has authored 167 papers receiving a total of 2.8k indexed citations (citations by other indexed papers that have themselves been cited), including 84 papers in Molecular Biology, 44 papers in Pulmonary and Respiratory Medicine and 40 papers in Cancer Research. Recurrent topics in Jing Hu's work include Cancer-related molecular mechanisms research (19 papers), RNA modifications and cancer (18 papers) and MicroRNA in disease regulation (18 papers). Jing Hu is often cited by papers focused on Cancer-related molecular mechanisms research (19 papers), RNA modifications and cancer (18 papers) and MicroRNA in disease regulation (18 papers). Jing Hu collaborates with scholars based in China, United States and Canada. Jing Hu's co-authors include Xiangwei Zhao, Yuanjin Zhao, Zhongze Gu, Bo Han, Juan Li, Ming Xu, Peng Su, Mei Qi, Gengyin Zhou and Chongyun Bao and has published in prestigious journals such as Advanced Materials, Journal of Biological Chemistry and Nature Communications.

In The Last Decade

Jing Hu

155 papers receiving 2.8k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Jing Hu China 28 1.4k 635 577 394 362 167 2.8k
Zhiqiang Li China 30 1.5k 1.1× 894 1.4× 424 0.7× 360 0.9× 490 1.4× 151 3.6k
Xinxin Wang China 29 1.6k 1.2× 966 1.5× 412 0.7× 354 0.9× 441 1.2× 165 3.0k
X Y Feng China 30 1.2k 0.9× 631 1.0× 682 1.2× 282 0.7× 374 1.0× 196 3.9k
Yong Xin China 31 1.1k 0.8× 445 0.7× 345 0.6× 215 0.5× 266 0.7× 136 3.0k
Hongyi Zhang China 31 1.7k 1.3× 775 1.2× 724 1.3× 279 0.7× 264 0.7× 154 4.2k
Keqing Shi China 39 1.4k 1.0× 888 1.4× 585 1.0× 372 0.9× 599 1.7× 209 5.2k
Jong Young Choi South Korea 36 1.2k 0.9× 460 0.7× 678 1.2× 457 1.2× 468 1.3× 239 5.2k
Wen Xu China 32 1.8k 1.3× 747 1.2× 1.1k 1.9× 672 1.7× 243 0.7× 157 4.2k
Shen Hu United States 33 2.1k 1.5× 474 0.7× 319 0.6× 263 0.7× 626 1.7× 92 4.4k

Countries citing papers authored by Jing Hu

Since Specialization
Citations

This map shows the geographic impact of Jing Hu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jing Hu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jing Hu more than expected).

Fields of papers citing papers by Jing Hu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jing Hu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jing Hu. The network helps show where Jing Hu may publish in the future.

Co-authorship network of co-authors of Jing Hu

This figure shows the co-authorship network connecting the top 25 collaborators of Jing Hu. A scholar is included among the top collaborators of Jing Hu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jing Hu. Jing Hu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Hu, Jing, Mengyao Liu, Meng Guo, et al.. (2025). A potent protective bispecific nanobody targeting Herpes simplex virus gD reveals vulnerable epitope for neutralizing. Nature Communications. 16(1). 4196–4196. 3 indexed citations
2.
Han, Bo, Jing Hu, Ping Liu, et al.. (2025). CUL4B regulates thyroid cancer differentiation and treatment sensitivity by ubiquitinating ARID1A. Translational Oncology. 56. 102389–102389.
3.
Hu, Jing, Jing Zhang, Bo Han, et al.. (2024). PLXNA1 confers enzalutamide resistance in prostate cancer via AKT signaling pathway. Neoplasia. 57. 101047–101047. 1 indexed citations
4.
Liu, Peiqi, Guanghao Zhu, Hairong Zeng, et al.. (2024). Human UDP-glucuronosyltransferase 1As catalyze aristolochic acid D O-glucuronidation to form a lesser nephrotoxic glucuronide. Journal of Ethnopharmacology. 328. 118116–118116. 3 indexed citations
5.
6.
Hu, Jing, et al.. (2024). Fluorine in the pharmaceutical industry: Synthetic approaches and application of clinically approved fluorine-enriched anti-infectious medications. European Journal of Medicinal Chemistry. 271. 116446–116446. 13 indexed citations
7.
Xu, Zhihao, Jing Hu, Yunru Yang, et al.. (2024). The molecular mechanisms of CD8+ T cell responses to SARS-CoV-2 infection mediated by TCR-pMHC interactions. Frontiers in Immunology. 15. 1468456–1468456. 2 indexed citations
8.
9.
Xu, Zhihao, Jing Hu, Zhuan Liu, et al.. (2024). Structural insights into immune escape at killer T cell epitope by SARS-CoV-2 Spike Y453F variants. Journal of Biological Chemistry. 300(8). 107563–107563. 4 indexed citations
10.
Chen, Ling, et al.. (2024). Unveiling the multifaceted role of adropin in various diseases (Review). International Journal of Molecular Medicine. 54(4). 8 indexed citations
11.
Wang, Xueli, Bo Han, Feifei Sun, et al.. (2023). A trio of tumor suppressor miRNA downregulates CREB5 dependent transcription to modulate neoadjuvant hormonal therapy sensitivity. Neoplasia. 36. 100875–100875. 1 indexed citations
12.
Hu, Jing, et al.. (2023). The role of glutamate receptors in the regulation of the tumor microenvironment. Frontiers in Immunology. 14. 1123841–1123841. 41 indexed citations
13.
Hu, Jing, Luyao Wang, Haifeng Yang, et al.. (2022). Key domains and residues of the receptor MRGPRX1 recognizing the peptide ligand BAM8-22. Peptides. 161. 170927–170927. 2 indexed citations
14.
Sun, Feifei, Jing Hu, Zeyuan Yu, et al.. (2022). RUVBL1 promotes enzalutamide resistance of prostate tumors through the PLXNA1-CRAF-MAPK pathway. Oncogene. 41(23). 3239–3250. 18 indexed citations
15.
Zhang, Wenbo, Feifei Sun, Jing Hu, et al.. (2020). KIF15-Mediated Stabilization of AR and AR-V7 Contributes to Enzalutamide Resistance in Prostate Cancer. Cancer Research. 81(4). 1026–1039. 57 indexed citations
16.
Hu, Jing, Chuanliang Cui, Wenxian Yang, et al.. (2020). Using deep learning to predict anti-PD-1 response in melanoma and lung cancer patients from histopathology images. Translational Oncology. 14(1). 100921–100921. 48 indexed citations
17.
Hu, Jing, Peng Su, Meng Jiao, et al.. (2018). TRPS1 Suppresses Breast Cancer Epithelial-mesenchymal Transition Program as a Negative Regulator of SUZ12. Translational Oncology. 11(2). 416–425. 26 indexed citations
18.
Mao, Qi, Meng Jiao, Jing Hu, et al.. (2017). CUL4B promotes gastric cancer invasion and metastasis-involvement of upregulation of HER2. Oncogene. 37(8). 1075–1085. 39 indexed citations
19.
Wang, Weishan, Jing Zhang, Tao Lin, et al.. (2014). SOX4 is associated with poor prognosis in cholangiocarcinoma. Biochemical and Biophysical Research Communications. 452(3). 614–621. 26 indexed citations
20.
Lam, Siew Hong, Choong Yong Ung, Mya Myintzu Hlaing, et al.. (2013). Molecular insights into 4-nitrophenol-induced hepatotoxicity in zebrafish: Transcriptomic, histological and targeted gene expression analyses. Biochimica et Biophysica Acta (BBA) - General Subjects. 1830(10). 4778–4789. 39 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Zhiqiang Li Breakdown of academic impact, for papers by Xinxin Wang Breakdown of academic impact, for papers by X Y Feng Breakdown of academic impact, for papers by Yong Xin Breakdown of academic impact, for papers by Hongyi Zhang Breakdown of academic impact, for papers by Keqing Shi Breakdown of academic impact, for papers by Jong Young Choi Breakdown of academic impact, for papers by Wen Xu Breakdown of academic impact, for papers by Shen Hu
Rankless by CCL
2026